Skip to main content

DALRADA FINANCIAL CORPORATION (OTCQB: DFCO)

Investor Connection

DALRADA FINANCIAL CORPORATION (OTCQB: DFCO)

Investor Connection

Are you an investor in Dalrada yet?

If not, let’s do some due diligence.

Overview

Dalrada Financial Corporation (OTCQB: DFCO) is a multi-national holding company that develops, manufactures, and sells a robust suite of products and services in the Clean Energy and Health Care sectors. Dalrada’s core segments include Dalrada Climate Technology, which offers cutting-edge heat pump technology for industrial and residential applications, and Genefic Specialty Pharmacy, which provides end-to-end prescription services as well as patient advocacy and support.

Dalrada Financial Corporation consistently drives innovation that delivers maximum impact, bringing increased value to its shareholders.

Executives

Brian Bonar
Dalrada Founder & CEO

Kyle McCollum
EVP of Finance and Administration

William Bonar
EVP of R&D and Manufacturing

David Pickett
EVP of Sales and Marketing

Company Video Updates

What’s new with Dalrada? Watch for updates as we continue to develop products and services for the betterment of humankind, enriching the lives of people around the world through our clean energy technology, healthcare systems, and much more.

Business Segments

Discover how Dalrada is driving positive environmental and social impacts through innovative subsidiaries while delivering exceptional value to shareholders.

Dalrada Climate Technology

Dalrada Climate Technology delivers state-of-the-art innovation in the form of energy efficiency products and services ideal for customizable sustainability projects. With an impressive lineup of next-generation commercial heat pumps and home heat pumps designed to minimize harmful emissions while maximizing cost savings, Dalrada is a top heat pump manufacturer, building solutions that reduce energy consumption, minimize carbon footprints, increase operational efficiencies, and provide lower energy costs for clients.

Genefic Healthcare

Genefic proudly creates improved health outcomes with redesigned health systems and reimagined patient care. Genefic Specialty Pharmacy is redefining personalized healthcare through unique medications like biologics and biosimilars that are used to treat rare or complex health problems. Making a positive global impact by keeping people safe with an exciting core of frontline health products and services that provide a better quality of life for people around the world is what defines Genefic and marks the company’s success.

Recent News

May 21, 2024 in PR, Press Release, Press Releases, PRs

Dalrada Financial Corporation Healthcare Subsidiary, Genefic, Inc., Acquires IV Services Infusion Pharmacy

Company enters $42 billion marketplace with acquisition of established and successful infusion pharmacy.
Read More
May 16, 2024 in PR, Press Release, Press Releases, PRs

Dalrada Financial Corporation Files Form 10-Q, Announces Third Quarter Revenue of $10.3 Million

Company’s pharmaceutical subsidiary continues to drive impressive growth accounting for nearly 80% of Q3 2024 revenue
Read More
April 23, 2024 in PR, Press Release, Press Releases, PRs

Dalrada Financial Corporation’s Wholly-Owned Subsidiary, Genefic, Inc. Announces New Telemedicine Services, Enters Booming Weight Loss Drug Market

Dalrada's pharmaceutical subsidiary plans on capturing a large portion of a growing market with an innovative prescription method.
Read More
April 10, 2024 in PR, Press Release, Press Releases, PRs

Dalrada Financial Corporation Files Patent Application for Proprietary Technology that Creates Carbon Utility Tokens

Company stakes its claim in the carbon market with unique software and hardware system for generating, validating, and trading carbon tokens.
Read More

Recent Financial Presentations

Q3 2024 Earnings Presentation

Download PDF

Q2 2024 Earnings Presentation

Download PDF

Q1 2024 Earnings Presentation

Download PDF

Fiscal 2023 Earnings Presentation

Download PDF

SEC Filings

Form Type

Filed

Period

Download

10-Q

Q3 2024

05/14/2024

03/31/2023

10-Q

Q2 2024

02/14/2024

12/31/2023

10-Q

Q1 2024

11/14/2023

09/30/2023

Form Type

Filed

Period

Download

10-K

Fiscal 2023

10/19/2023

06/30/2023

10-Q

Q3 2023

05/15/2023

03/31/2023

10-Q

Q2 2023

02/14/2023

12/31/2022

10-Q

Q1 2023

11/29/2022

09/30/2022

DFCO Stock Chart

$DFCO achieves high-growth potential by delivering accessibility and sustainability through unique business divisions that focus on clean energy, precision manufacturing, and technology.

Follow Dalrada on Social Media

Let’s get social: check out the latest Dalrada news and updates via our social media channels. Don’t forget to like, share, and subscribe!

Investment Opportunities

San Diego Office
600 La Terraza Blvd.
Escondido, CA 92025

Investment Opportunities: investors@dalrada.com
Phone: 858.326.2661

General Inquiries: DFCOinquiries@dalrada.com
Phone: 858.283.1253

Skip to content